Levofloxacin

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

57 Suppliers, 27 USDMF, 11 JDMF, 7 EU WC, 26 KDMF, 21 NDC API, 25 Listed Suppliers

DEVELOPMENTS

3 Drug(s) in Development

3 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

3 Suppliers

3 Suppliers

DOSSIERs // Finished Dosage Forms

501 Dossiers, 119 FDA Orange Book, 189 Europe, 19 Canada, 57 South Africa, 117 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION/DROPS;OPHTHALMIC - 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION/DROPS;OPHTHALMIC - 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 250MG/10ML

RELATED EXCIPIENT COMPANIES

Suppliers, 30 Kerry, 24 BASF, 23 Roquette, 15 Actylis, 14 Seppic, 13 Microlex e.U, 12 Sigachi Industries, 11 Gangwal Chemicals, 10 Corel Pharma Chem, 10 Gangwal Healthcare, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 Boai NKY Pharmaceuticals Ltd, 6 DFE Pharma, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 Nanjing Well Pharmaceutical, 6 Lonza Capsugel, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 4 Finar, 4 Vasa Pharmachem, 4 SPI Pharma, 4 Pharmatrans-Sanaq, 4 Prachin Chemical, 3 Ulanqab Kema New Material, 3 Kima Chemical, 3 DKSH, 2 Seqens, 2 Nomisma Healthcare, 2 Jai Radhe Sales, 2 The Dow Chemical Company, 2 Rochem International Inc, 1 Clariant, 1 Alcedo Pharmachem, 1 Pfanstiehl, 1 Nanjing Bold Chemical, 1 ACG Worldwide, 1 Aeon Procare, 1 Qualicaps, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Bioplus Life Sciences, 1 Pharm-RX Chemical, 1 Shanghai Welltone Material Technology Co., Ltd

EXCIPIENTS BY APPLICATIONS

66 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 42 Disintegrants & Superdisintegrants, 34 Direct Compression, 30 Solubilizers, 28 Controlled & Modified Release, 25 Thickeners and Stabilizers, 24 Granulation, 22 Parenteral, 17 Topical, 16 Lubricants & Glidants, 13 Film Formers & Plasticizers, 13 Co-Processed Excipients, 13 Taste Masking, 9 Chewable & Orodispersible Aids, 6 API Stability Enhancers, 6 Emulsifying Agents, 5 Empty Capsules, 5 Rheology Modifiers, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

15 US Medicaid Prescriptions, 193 Finished Drug Prices

MARKET PLACE

28 APIs, 34 DOSSIERS // FDF, 1 Intermediates

PATENTS

9 Health Canada Patents

9 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 2 Analytical Solutions, 2 USP Standards, 19 Other Ref. Standards

DIGITAL CONTENT

4 Data Compilation & Company Tracker #PharmaFlow, 48 News

List of USP reference standards related to Levofloxacin

Levofloxacin

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

57 Suppliers

27 USDMF

11 JDMF

7 EU WC

26 KDMF

21 NDC API

25 Listed Suppliers

DEVELOPMENTS

3 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

3 Suppliers

DOSSIERs // Finished Dosage Forms

501 Dossiers

119 FDA Orange Book

189 Europe

19 Canada

57 South Africa

117 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION/DROPS;OPHTHALMIC - 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION/DROPS;OPHTHALMIC - 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;ORAL - 250MG/10ML

RELATED EXCIPIENT COMPANIES

Suppliers

30 Kerry

24 BASF

23 Roquette

15 Actylis

14 Seppic

13 Microlex e.U

12 Sigachi Industries

11 Gangwal Chemicals

10 Corel Pharma Chem

10 Gangwal Healthcare

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

8 Boai NKY Pharmaceuticals Ltd

6 DFE Pharma

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 Nanjing Well Pharmaceutical

6 Lonza Capsugel

5 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

4 Finar

4 Vasa Pharmachem

4 SPI Pharma

4 Pharmatrans-Sanaq

4 Prachin Chemical

3 Ulanqab Kema New Material

3 Kima Chemical

3 DKSH

2 Seqens

2 Nomisma Healthcare

2 Jai Radhe Sales

2 The Dow Chemical Company

2 Rochem International Inc

1 Clariant

1 Alcedo Pharmachem

1 Pfanstiehl

1 Nanjing Bold Chemical

1 ACG Worldwide

1 Aeon Procare

1 Qualicaps

1 Qianhao Chemical (Hebei) Co., Ltd

1 Bioplus Life Sciences

1 Pharm-RX Chemical

1 Shanghai Welltone Material Technology Co., Ltd

TABLET;ORAL - 250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 750MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION/DROPS;OPHTHALMIC - 0.5% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION/DROPS;OPHTHALMIC - 1.5% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons